the effectiveness of ACT & CFT in Diabetic non-clinical patients Depressed

Not Applicable

• Conditions: Diabetics.; Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC); E11.00

• Registration Number: IRCT20191012045072N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

Willingness to participate

Diabetes disease at least for 2 years
High-fat lipoprotein( for women less than 60 mg/dl, for man less than 40 mg/dl)
Low-Fat lipoprotein (100-130 mg/dl)
Cholesterol less than 200 mg/dl
Triglycerides (150 -160)
Fasting blood sugar less than 110
Hemoglobin A1c less than 5.5

Exclusion Criteria

kidney, heart, liver, lung, inflammatory, chronic gastrointestinal disease, thyroid disorder
Insulin-dependent injection
Taking estrogen and progesterone
Addiction
Lactase intolerance
Taking herbal medicines
obvious psychology disorder

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma lipids and lipoproteins. Timepoint: One month before the intervention, 7 and 30 days after the intervention. Method of measurement: CBC test and use of Pars Azmon laboratory kits.;Negative self-referential processors. Timepoint: 7 and 30 days after the intervention. Method of measurement: Anger rumination scale, self-critical rumination, Diabetes distress screening scale Questionnaire.;Psychological symptoms. Timepoint: 30 days before the intervention and 7 and 30 after the intervention. Method of measurement: Pennsylvania Worry Questionnaire, Diabetes Anxiety -Depression scale type 2 , Patient Health.;Blood sugar index. Timepoint: One month before the intervention, 7 and 30 after the intervention. Method of measurement: CBC test and use of Pars Azmon laboratory kits.